Shanghai Zhongshan Hospital: Adenocarcinoma trials

The registry lists 12 Adenocarcinoma studies with Shanghai Zhongshan Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 5No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-MakingRecruitingNCT07856017
• Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical StudyRecruitingNCT06794073Not applicable
• The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT06587425Phase 2
• A Prospective Observation Registry Study on the Alimentary Reconstruction After Radical Proximal GastrectomyRecruitingNCT05539105
• A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach AdenocarcinomaRecruitingNCT04799548Phase 2
• Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung AdenocarcinomaStatus unknownNCT05185544
• Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort StudyStatus unknownNCT04737551
• Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal CancerStatus unknownNCT04503967Phase 2
• Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung AdenocarcinomaStatus unknownNCT03641105
• Neoadjuvant Chemoradiation Plus PD-1 Antibody(SHR-1210) in Locally Advanced Proximal Stomach AdenocarcinomaStatus unknownNCT03631615Phase 2
• Trastuzumab Based Therapy in HER2 Positive AGCCompletedNCT03024450
• Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric AdenocarcinomaStatus unknownNCT01880632Phase 2